The landscape of dementia diagnosis has developed radically with the appearance of sophisticated biomarkers, such as amyloid PET scans, tau imaging, and blood-primarily based tests that will detect Alzheimer's pathology a long time just before indicators emerge. Though these technological developments signify outstanding development in being familiar with neurodegenerative disorders, https://peterc086ajs5.blogdemls.com/profile